National Day Pharmaceutical JSC (HSTC:NDP) YoY EBITDA Growth: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:NDP National Day Pharmaceutical JSC HSTC:NDP
18 GF Score
Price ₫23,000.00
View Full Analysis

What is National Day Pharmaceutical JSC YoY EBITDA Growth?

National Day Pharmaceutical JSC HSTC:NDP 18 YoY EBITDA Growth is 0.00% as of . 20. GuruFocus rates HSTC:NDP with a GF Score™ of 18/100.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. National Day Pharmaceutical JSC's YoY EBITDA Growth for the quarter that ended in . 20 was 0.00%.

National Day Pharmaceutical JSC's EBITDA per Share for the six months ended in . 20 was ₫0.00.

National Day Pharmaceutical JSC YoY EBITDA Growth Related Terms

National Day Pharmaceutical JSC YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for National Day Pharmaceutical JSC's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

National Day Pharmaceutical JSC YoY EBITDA Growth Chart

National Day Pharmaceutical JSC Annual Data
Trend
YoY EBITDA Growth

National Day Pharmaceutical JSC Semi-Annual Data
YoY EBITDA Growth
HSTC:NDP
18GF Score
National Day Pharmaceutical JSC HSTC:NDP
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

National Day Pharmaceutical JSC YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

National Day Pharmaceutical JSC's YoY EBITDA Growth for the fiscal year that ended in . 20 is calculated as:

YoY EBITDA Growth (A: . 20 )
=(EBITDA per Share (A: . 20 )-EBITDA per Share (A: . 20 ))/ | EBITDA per Share (A: . 20 ) |
=(-)/ | |
=N/A %

National Day Pharmaceutical JSC's YoY EBITDA Growth for the quarter that ended in . 20 is calculated as:

YoY EBITDA Growth (Q: . 20 )
=(EBITDA per Share (Q: . 20 )-EBITDA per Share (Q: . 20 )) / | EBITDA per Share (Q: . 20 ) |
=(-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 0.00% mean?
National Day Pharmaceutical JSC (HSTC:NDP) has a YoY EBITDA Growth of 0.00% as of . 20. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for National Day Pharmaceutical JSC and its competitors.
Is National Day Pharmaceutical JSC's YoY EBITDA Growth too high?
National Day Pharmaceutical JSC's current YoY EBITDA Growth is 0.00%. Overall, National Day Pharmaceutical JSC has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does National Day Pharmaceutical JSC's YoY EBITDA Growth compare to ?
National Day Pharmaceutical JSC's YoY EBITDA Growth of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for National Day Pharmaceutical JSC and its competitors. National Day Pharmaceutical JSC's current YoY EBITDA Growth is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Day Pharmaceutical JSC stock overvalued right now?
National Day Pharmaceutical JSC (HSTC:NDP) has a current YoY EBITDA Growth of 0.00%. The current YoY EBITDA Growth is 0.00%. National Day Pharmaceutical JSC's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For National Day Pharmaceutical JSC (HSTC:NDP), the current YoY EBITDA Growth is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

National Day Pharmaceutical JSC Business Description

Comparable Companies
Address 299/22 Ly Thuong Kiet, Ward 15, District 1.1, Ho Chi Minh, VNM
National Day Pharmaceutical JSC is a pharmaceutical manufacturing company. The company manufactures oral tubes, liquid pills, powder pills, tablets, film-coated tablets, sugar-coated tablets, capsules, and others.
18GF Score

Get the complete analysis for HSTC:NDP

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫23,000.00
Price